Formulary Search Results for: CALCIUM AND VITAMIN D
9.6.6 Vitamin K - View Category
Prescribing Notes:
Menadiol sodium phosphate - a water soluble oral preparation to prevent vitamin K deficiency in malabsorption syndromes. Contraindicated in late pregnancy. BNF link
Phytomenadione - used for the prophylaxis and treatment of vitamin K deficiency bleeding and for the reversal of the anticoagulant effect of warfarin. It is available as tablets and as injection. BNF link
8.1.2 Anthracyclines and other cytotoxic antibiotics - View Category
Restrictions:
Restricted to specialist use only. Use in the treatment of ovarian cancer is restricted to use in accordance with regional protocol. It is not approved for the treatment of HIV-related Kaposi’s sarcoma, metastatic breast cancer or second line treatment for progressive multiple myeloma.
8.1.2 Anthracyclines and other cytotoxic antibiotics - View Category
8.3.1 Oestrogens - View Category
8.3 Sex hormones and hormone antagonists in malignant disease - View Category
Restrictions: The treatment of adults with castration-resistant prostate cancer, symptomatic bone metastases and no known visceral metastases is restricted to specialist use in accordance with regional protocol (in development) when the service infrastructure is in place to support the safe delivery of this treatment.
7.1.1 Prostaglandins and oxytocics - View Category
7.2.2 Vaginal and vulval infections - View Category
Restrictions:
The treatment of bacterial vaginosis is restricted to use in patients for whom the initial treatment is not effective or well tolerated.
7.4.1 Drugs for urinary retention - View Category
Restrictions:
Restricted to specialist initiation.
Prescribing Notes:
Only suitable for patient with enlargement of the prostate.
7.4.2 Drugs for urinary frequency, enuresis, and incontinence - View Category
Restrictions:
Desmopressin oral lyophilisate for the symptomatic treatment of nocturia due to idiopathic nocturnal polyuria in adults is restricted to specialist initiation by a consultant gynaecologist/urogynaecologist for use in patients aged 65 years and above (also see prescribing notes below).
Prescribing Notes:
- A positive diagnosis should be made following analysis of a 3-day volume chart
- Assessment of efficacy is required every 3 months
- Monitoring arrangements will be the responsibility of secondary care
7.4.2 Drugs for urinary frequency, enuresis, and incontinence - View Category
Prescribing Notes:
Pelvic floor exercises are considered the first line treatment for stress incontinence in women.